Early benefit from structured care with Atorvastatin in patients with coronary heart disease and diabetes mellitus. A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.

被引：0
|
作者：
Athyros, VG
Papageorgiou, AA
Symeonidis, AN
Didangelos, TP
Pehlivanidis, AN
Bouloukos, VI
Mikhailidis, DP
机构：
[1] Aristotle Univ Thessaloniki, Atherosclerosis Unit, GR-54006 Thessaloniki, Greece
[2] Greek Soc Gen Practitioners, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Ctr Diabet, GR-54006 Thessaloniki, Greece
[4] Univ London Royal Free Hosp, London NW3 2QG, England
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
206
引用
收藏
页码：A74 / A75
页数：2
相关论文
共 50 条
  • [21] Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study
    Athyros, VG
    Mikhailidis, DP
    Papageorgiou, AA
    Bouloukos, VI
    Pehlivanidis, AN
    Symeonidis, AN
    Kakafika, AI
    Daskalopoulou, SS
    Elisaf, M
    PLATELETS, 2005, 16 (02) : 65 - 71
  • [22] Hypotriglyceridemic and non-lipid effects of atorvastatin and simvastatin therapy in coronary heart disease patients with combined hyperlipidemia and type 2 diabetes mellitus
    Vasutina, E
    Metelskaya, VA
    Akhmedzhanov, NM
    Ratnikova, LA
    Oganov, RG
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 22 - 22
  • [23] Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
    Knopp, Robert H.
    D'Emden, Michael
    Smilde, Johan G.
    Pocock, Stuart J.
    DIABETES CARE, 2006, 29 (07) : 1478 - 1485
  • [24] An assessment of the efficacy of atorvastatin in achieving LDL cholesterol target levels in patients with coronary heart disease: A general practice study
    Neil, H
    Fowler, G
    Patel, H
    Eminton, Z
    Maton, S
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (06) : 422 - +
  • [25] Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) - Response to Knopp
    Gazi, Irene F.
    Mikhailidis, Dimitri P.
    DIABETES CARE, 2006, 29 (11) : 2561 - 2561
  • [26] Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS trial)
    Deedwania, Prakash C.
    Gupta, Milan
    Stein, Michael
    Ycas, Joseph
    Gold, Alex
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11): : 1538 - 1543
  • [27] Old and new diagnostic criteria of diabetes mellitus: an analysis in patients with coronary heart disease.
    Rein, Philipp
    Saely, Christoph H.
    Vonbank, Alexander
    Beer, Stefan
    Boehnel, Christian
    Jankovic, Vlado
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 : S17 - S17
  • [28] Analysis of Glycometabolic State and Clinical Indexes in Patients with Coronary Heart Disease and Undiagnosed Diabetes Mellitus
    Wu, Xing
    Li, Hongwei
    CIRCULATION, 2010, 122 (02) : E189 - E189
  • [29] Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease A protocol for systematic review and meta-analysis
    Li, Ke
    Liu, Meng-Meng
    Yang, Xin
    Chen, Li
    Geng, Hui
    Luo, Wei
    Ma, Jie
    MEDICINE, 2021, 100 (24) : E26340
  • [30] Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study
    Dezsi, Csaba Andras
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (05) : 1902 - 1909
12345